Has Stephen Brown received payments from drug or device companies?

Yes. Drug and device makers reported $5,245 in general payments to Stephen Brown across 183 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Stephen Brown did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Stephen Brown come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Stephen Brown

Psychiatry · Glen Allen, VANPI 1275709651

Payments from drug & device makers

$5,245in general payments, 2019–2025

Across 183 payments — averaging $28.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Otsuka America Pharmaceutical, Inc.$750
Vanda Pharmaceuticals Inc.$589
Takeda Pharmaceuticals U.S.A., Inc.$533
Neurocrine Biosciences, Inc.$494
Sunovion Pharmaceuticals Inc.$471
plus $1K from 10 others

What the payments were for

Food & beverage$5,19699%
Education$491%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	59	$1,349
Otsuka America Pharmaceutical, Inc.	15	$750
Vanda Pharmaceuticals Inc.	18	$589
Takeda Pharmaceuticals U.S.A., Inc.	34	$533
Neurocrine Biosciences, Inc.	11	$494
Sunovion Pharmaceuticals Inc.	18	$471
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	4	$223
Axsome Therapeutics, Inc.	3	$212
Idorsia Pharmaceuticals US Inc	6	$148
Teva Pharmaceuticals USA, Inc.	2	$137
Johnson & Johnson	1	$115
Lundbeck LLC	3	$60
Shire North American Group Inc	3	$56
Corium, LLC	3	$50
Eisai Inc.	2	$36
Jazz Pharmaceuticals Inc.	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,245 in reported general payments places this provider in the 90th percentile of 884 psychiatry providers in Virginia.

See all psychiatry providers in Virginia →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
VraylarCariprazine Hcl	25	$35,054
TrintellixVortioxetine Hydrobromide	14	$9,870
Atomoxetine Hcl	12	$776
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	29	$714
Duloxetine Hcl	20	$260
Trazodone Hcl	31	$222
Hydroxyzine Pamoate	15	$157
Lithium Carbonate	15	$131
Topiramate	12	$80
Diazepam	21	$79
Lamotrigine	20	$71
Lorazepam	24	$67
Paroxetine Hcl	11	$53
Clonazepam	12	$47
Buspirone Hcl	11	$34

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AbbVieVraylar	$1,349	$35,05425 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix	$533	$9,87014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 884 psychiatry providers in Virginia.

Other psychiatry in Glen Allen

Kent McDanielGlen Allen$2.1M
Niku SinghFalls Church$2.5M
David ScheidererRoanoke$2.4M
Jasdeep MiglaniManassas$958K
Frederick MoellerRichmond$678K
David SpiegelNorfolk$565K
Christopher van EyckStafford$392K
Anita ClaytonCharlottesville$356K
Anita KablingerRoanoke$333K
William YetterVirginia Beach$312K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →